Dimensional Fund Advisors LP Morphic Holding, Inc. Transaction History

Dimensional Fund Advisors LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$26.12 - $34.07 $337,914 - $440,763	-12,937 Reduced 5.85%	208,225 $7.09 Million
Q1 2024 May 10, 2024	SELL	$26.64 - $40.31 $374,664 - $566,919	-14,064 Reduced 5.98%	221,162 $7.78 Million
Q4 2023 Feb 07, 2024	SELL	$19.95 - $31.0 $5.88 Million - $9.13 Million	-294,587 Reduced 55.6%	235,226 $6.79 Million
Q3 2023 Nov 09, 2023	BUY	$21.33 - $59.42 $814,358 - $2.27 Million	38,179 Added 7.77%	529,813 $12.1 Million
Q2 2023 Aug 09, 2023	BUY	$34.33 - $62.11 $6.34 Million - $11.5 Million	184,666 Added 60.16%	491,634 $28.2 Million
Q1 2023 May 12, 2023	BUY	$26.01 - $48.69 $1.45 Million - $2.71 Million	55,726 Added 22.18%	306,968 $11.6 Million
Q4 2022 Feb 09, 2023	BUY	$24.14 - $30.37 $1.45 Million - $1.82 Million	60,081 Added 31.43%	251,242 $6.72 Million
Q3 2022 Nov 10, 2022	SELL	$22.23 - $33.37 $3.44 Million - $5.17 Million	-154,816 Reduced 44.75%	191,161 $5.41 Million
Q2 2022 Aug 12, 2022	SELL	$19.74 - $43.01 $388,443 - $846,350	-19,678 Reduced 5.38%	345,977 $7.51 Million
Q1 2022 May 13, 2022	BUY	$36.25 - $52.02 $2.1 Million - $3.02 Million	58,015 Added 18.86%	365,655 $14.7 Million
Q4 2021 Feb 09, 2022	BUY	$43.27 - $65.72 $3.08 Million - $4.68 Million	71,138 Added 30.08%	307,640 $14.6 Million
Q3 2021 Nov 12, 2021	BUY	$53.61 - $67.5 $6.22 Million - $7.83 Million	116,020 Added 96.3%	236,502 $13.4 Million
Q2 2021 Aug 12, 2021	BUY	$45.13 - $64.99 $5.44 Million - $7.83 Million	120,482 New	120,482 $6.92 Million

4.7M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.